1 Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract 2019;157:107843.
2 Kim D, Li AA, Cholankeril G, et al. Trends in overall, cardiovascular and cancer-related mortality among individuals with diabetes reported on death certificates in the United States between 2007 and 2017. Diabetologia 2019;62:1185–94.
3 Campbell PT, Newton CC, Patel AV, et al. Diabetes and cause- specific mortality in a prospective cohort of one million U.S. adults. Diabetes Care 2012;35:1835–44.
4 World Health Organization. Fact sheets: the top 10 causes of death. Available: https://www.who.int/news-room/fact-sheets/detail/the- top-10-causes-of-death [Accessed 4 Jun 2021].
5 World Health Organization & International Diabetes Federation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia : report of a WHO/IDF consultation, 2006. Available: http://whqlibdoc.who.int/publications/2006/9241594934_eng.pdf? ua=1 [Accessed 20 Sep 2020].
6 Coutinho M, Gerstein HC, Wang Y, et al. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999;22:233–40.
7 Levitan EB, Song Y, Ford ES, et al. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med 2004;164:2147–55.
8 Khalil M, Power N, Graham E, et al. The association between sleep and diabetes outcomes - A systematic review. Diabetes Res Clin Pract 2020;161:108035.
9 Lee SWH, Ng KY, Chin WK. The impact of sleep amount and sleep quality on glycemic control in type 2 diabetes: a systematic review and meta-analysis. Sleep Med Rev 2017;31:91–101.
10 Mullington JM, Haack M, Toth M, et al. Cardiovascular, inflammatory, and metabolic consequences of sleep deprivation. Prog Cardiovasc Dis 2009;51:294–302.
11 Cappuccio FP, D'Elia L, Strazzullo P, et al. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care 2010;33:414–20.
12 Wang C, Bangdiwala SI, Rangarajan S, et al. Association of estimated sleep duration and naps with mortality and cardiovascular events: a study of 116 632 people from 21 countries. Eur Heart J 2019;40:1620–9.
13 Cappuccio FP, D'Elia L, Strazzullo P, et al. Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep 2010;33:585–92.
14 Kwok CS, Kontopantelis E, Kuligowski G, et al. Self-Reported sleep duration and quality and cardiovascular disease and mortality: a dose-response meta-analysis. J Am Heart Assoc 2018;7:e008552.
15 Centers for Disease Control and Prevention. National Center for Health Statistics. National health and nutrition examination survey. about the National health and nutrition examination survey. Available: https://www.cdc.gov/nchs/nhanes/about_nhanes.htm [Accessed 20 Sep 2020].
16 Saydah SH, Miret M, Sung J, et al. Postchallenge hyperglycemia and mortality in a national sample of U.S. adults. Diabetes Care 2001;24:1397–402.
17 Inoue K, Nianogo R, Telesca D. Low HbA1c levels and all-cause or cardiovascular mortality among people without diabetes: the US National health and nutrition examination survey 1999–2015. Int J Epidemiol 2020;6.
18 National health and nutrition examination survey, 2013-2014 data documentation, Codebook, and frequencies, oral glucose tolerance test. Available: https://wwwn.cdc.gov/Nchs/Nhanes/2013-2014/ OGTT_H.htm [Accessed 20 Sep 2020].
19 Centers for Disease Control and Prevention. Sleep and Sleep Disorders, How Much Sleep Do I Need [Internet]? Available: https:// www.cdc.gov/sleep/about_sleep/how_much_sleep.html [Accessed 28 Feb 2021].
20 Consensus Conference Panel, Watson NF, Badr MS, et al. Joint consensus statement of the American Academy of sleep medicine and sleep research Society on the recommended amount of sleep for a healthy adult: methodology and discussion. Sleep 2015;38:1161–83.
21 National health and nutrition examination survey (2005-2014) Public- use linked mortality files (2015). Available: https://www.cdc.gov/ nchs/data-linkage/mortality-public.htm [Accessed 20 Sep 2020].
22 Inoue K, Tsujimoto T, Saito J, et al. Association between serum thyrotropin levels and mortality among euthyroid adults in the United States. Thyroid 2016;26:1457–65.
23 Cappuccio FP, Cooper D, D'Elia L, et al. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J 2011;32:1484–92.
24 Barrett-Connor E, Ferrara A. Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men. The Rancho bernardo study. Diabetes Care 1998;21:1236–9.
25 Huang Y, Cai X, Mai W, et al. Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. BMJ 2016;355:i5953.
26 Saydah SH, Loria CM, Eberhardt MS, et al. Subclinical states of glucose intolerance and risk of death in the U.S. Diabetes Care 2001;24:447–53.
27 Lindberg E, Theorell-Haglöw J, Svensson M, et al. Sleep apnea and glucose metabolism: a long-term follow-up in a community-based sample. Chest 2012;142:935–42.
28 Shan Z, Ma H, Xie M, et al. Sleep duration and risk of type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care 2015;38:529–37.
29 Gottlieb DJ, Punjabi NM, Newman AB, et al. Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med 2005;165:863–7.
30 Zheng B, Yu C, Lv J, et al. Insomnia symptoms and risk of cardiovascular diseases among 0.5 million adults: a 10-year cohort. Neurology 2019;93:e2110–20.
31 Clark AJ, Salo P, Lange T, et al. Onset of impaired sleep and cardiovascular disease risk factors: a longitudinal study. Sleep 2016;39:1709–18.
32 Krittanawong C, Tunhasiriwet A, Wang Z, et al. Association between short and long sleep durations and cardiovascular outcomes: a systematic review and meta-analysis. Eur Heart J Acute Cardiovasc Care 2019;8:762–70.
33 Krittanawong C, Kumar A, Wang Z, et al. Sleep duration and cardiovascular health in a representative community population (from NHANES, 2005 to 2016). Am J Cardiol 2020;127:149–55.
34 Eguchi K, Hoshide S, Ishikawa S, et al. Short sleep duration and type 2 diabetes enhance the risk of cardiovascular events in hypertensive patients. Diabetes Res Clin Pract 2012;98:518–23.
35 Centers for Disease Control and Prevention. Diabetes home, data and statistics, National diabetes statistics report, prevalence of prediabetes among adults. Available: https://www.cdc.gov/diabetes/ data/statistics-report/prevalence-of-prediabetes.html [Accessed 20 Sep 2020].
36 McAlpine CS, Kiss MG, Rattik S, et al. Sleep modulates haematopoiesis and protects against atherosclerosis. Nature 2019;566:383–7.
37 Swirski FK, Nahrendorf M. Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science 2013;339:161–6. Copinschi G. Metabolic and endocrine effects of sleep deprivation. Essent Psychopharmacol 2005;6:341–7.
38 Spiegel K, Tasali E, Penev P, et al. Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med 2004;141:846–50.
39 Taheri S, Lin L, Austin D, et al. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med 2004;1:e62.
40 Knutson KL, Spiegel K, Penev P, et al. The metabolic consequences of sleep deprivation. Sleep Med Rev 2007;11:163–78.
41 Edelstein SL, Knowler WC, Bain RP, et al. Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes 1997;46:701–10.
42 Edelstein SL, Knowler WC, Bain RP, et al. Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes 1997;46:701–10.
論文の公開元へ
